Lung Diseases Clinical Trials

77 recruitingLast updated: June 17, 2026

There are 77 actively recruiting lung diseases clinical trials across 49 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4. Top locations include Kansas City, Kansas, United States, Los Angeles, California, United States, Birmingham, Alabama, United States. Updated daily from ClinicalTrials.gov.


Lung Diseases Trials at a Glance

77 actively recruiting trials for lung diseases are listed on ClinicalTrialsFinder across 6 cities in 49 countries. The largest study group is Not Applicable with 23 trials, with the heaviest enrollment activity in Kansas City, Los Angeles, and Birmingham. Lead sponsors running lung diseases studies include Boehringer Ingelheim, Dalarna County Council, Sweden, and Eko Devices, Inc..

Browse lung diseases trials by phase

Treatments under study

About Lung Diseases Clinical Trials

Looking for clinical trials for Lung Diseases? There are currently 40 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 77 trials

Recruiting
Phase 1Phase 2

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.118 enrolled22 locationsNCT07407933
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Interstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim400 enrolled158 locationsNCT06806592
Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Interstitial Lung DiseasePulmonary HypertensionPulmonary Hypertension Due to Lung Diseases and Hypoxia
United Therapeutics900 enrolled67 locationsNCT06388421
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting
Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled6 locationsNCT05922761
Recruiting

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

SarcoidosisIdiopathic Pulmonary FibrosisInterstitial Lung Diseases+1 more
University of Chicago4,000 enrolled1 locationNCT00470327
Recruiting

Data Collection Using Eko Digital Devices in a Clinical Setting

Lung Diseases
Eko Devices, Inc.250 enrolled2 locationsNCT07227376
Recruiting
Phase 4

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled40 locationsNCT04263038
Recruiting
Not Applicable

Ultrasound and Respiratory Physiological Signals in Lung Diseases

UltrasoundChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+5 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS25 enrolled1 locationNCT06068647
Recruiting
Phase 3

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Carcinoma, Non-Small Cell LungResectable Lung Non-Small Cell CarcinomaLung Diseases
Fundación GECP129 enrolled32 locationsNCT06431633
Recruiting

Trikafta Exercise Study in Cystic Fibrosis

Cystic FibrosisLung Diseases
University of British Columbia20 enrolled1 locationNCT05279040
Recruiting
Not Applicable

Ventilator Pressure and Optimization of Compliance and Hemodynamics

Pulmonary Hypertension Due to Lung Diseases and HypoxiaBronchopulmonary DysplasiaExtreme Prematurity+2 more
University of Alabama at Birmingham24 enrolled1 locationNCT06512935
Recruiting

Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)

Lung Diseases, Interstitial
Boehringer Ingelheim312 enrolled1 locationNCT05819385
Recruiting
Phase 1

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

Upper respiratory tract infectionsrespiratory tract infectionCOVID-19 (SARS-CoV-2) infection+8 more
Pfizer18 enrolled1 locationNCT07552779
Recruiting
Phase 2

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Cardiovascular DiseasesFibrosisLung Diseases+3 more
Pulmovant, Inc.20 enrolled1 locationNCT07333183
Recruiting

Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients

Gynecologic CancerUltrasoundLung Diseases+1 more
Ain Shams University64 enrolled1 locationNCT06728709
Recruiting

Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients

Pulmonary Hypertension Due to Lung Diseases
Medical University of Graz80 enrolled1 locationNCT07498244
Recruiting
Not Applicable

Respiratory Muscles and Work of Breathing in Children

Lung DiseasesNeuromuscular DiseasesScoliosis+4 more
Assistance Publique - Hôpitaux de Paris550 enrolled1 locationNCT05051254
Recruiting
Not Applicable

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Lung Diseases, Interstitial
University Hospital, Montpellier24 enrolled1 locationNCT05722340
Recruiting
Not Applicable

Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.

Lung Diseases
University Hospital, Montpellier120 enrolled1 locationNCT05525312